Health care-associated pneumonia: identification and initial management in the ED

American Journal of Emergency Medicine

Volumn 26, Issue 6 SUPPL., 2008, Pages 1-11

  Abrahamian, Fredrick M ^a,b   DeBlieux, Peter M ^c   Emerman, Charles L ^d   Kollef, Marin H ^e   Kupersmith, Eric ^f   Leeper Jr , Kenneth V ^g   Paterson, David L ^h   Shorr, Andrew F ⁱ  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^g EMORY UNIVERSITY   (United States)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁱ GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CEFTOBIPROLE; CEPHALOSPORIN; CIPROFLOXACIN; ERTAPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIGECYCLINE; TOBRAMYCIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; AWARENESS; BACTERIUM CULTURE; CHEMOTHERAPY; COMMUNITY ACQUIRED PNEUMONIA; DISEASE CLASSIFICATION; EMERGENCY MEDICINE; EMERGENCY WARD; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGICAL DATA; EXPOSURE VARIABLE; FEMALE; HEALTH CARE ASSOCIATED PNEUMONIA; HEALTH CARE FACILITY; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INTENSIVE CARE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; NURSING HOME; OXYGEN THERAPY; PATHOGENESIS; PATIENT CARE; PNEUMONIA; PNEUMONIA SEVERITY INDEX; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; VENTILATOR ASSOCIATED PNEUMONIA; WOUND CARE;

ACETAMIDES; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; BETA-LACTAMS; CEPHALOSPORINS; CROSS INFECTION; EMERGENCY TREATMENT; FEMALE; HUMANS; LENGTH OF STAY; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MINOCYCLINE; OXAZOLIDINONES; PATIENT CARE TEAM; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; PRACTICE GUIDELINES AS TOPIC; RESPIRATION, ARTIFICIAL; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 46049101222     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2008.03.015     Document Type: Article

References (24)

1. McCaig L.F., and Burt C.W. National Hospital Ambulatory Medical Care Survey: 2002 Emergency Department summary. Adv Data (2004) 1-34
2. Hiramatsu K., and Niederman M.S. Health-care-associated pneumonia: a new therapeutic paradigm. Chest 128 (2005) 3784-3787
3. Kollef M.H., Shorr A., Tabak Y.P., et al. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 128 (2005) 3854-3862
4. Craven D.E. What is healthcare-associated pneumonia, and how should it be treated?. Curr Opin Infect Dis 19 (2006) 153-160
5. Gaynes R., and Edwards J.R. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 41 (2005) 848-854
6. El-Solh A.A., Sikka P., Ramadan F., et al. Etiology of severe pneumonia in the very elderly. Am J Respir Crit Care Med 163 (2001) 645-651
7. American Thoracic Society, and Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171 (2005) 388-416
8. Chastre J., and Fagon J.Y. Ventilator-associated pneumonia. Am J Respir Crit Care Med 165 (2002) 867-903
9. Craven D.E., Palladino R., and McQuillen D.P. Healthcare-associated pneumonia in adults: management principles to improve outcomes. Infect Dis Clin North Am 18 (2004) 939-962
10. Moran G.J., Krishnadasan A., Gorwitz R.J., et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355 (2006) 666-674
11. Naimi T.S., LeDell K.H., Como-Sabetti K., et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290 (2003) 2976-2984
12. Micek S.T., Kolleft K.E., Reichley R.M., et al. Healthcare-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 51 (2007) 3568-3573
13. Mandell L.A., Wunderink R.G., Anzueto A., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44 suppl (2007) S27-S72
14. Syrjala H., Broas M., Suramo I., et al. High-resolution computed tomography for the diagnosis of community-acquired pneumonia. Clin Infect Dis 27 (1998) 358-363
15. Waterer G.W., and Wunderink R.G. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Respir Med 95 (2001) 78-82
16. Moran G.J., and Abrahamian F.M. Blood cultures for community-acquired pneumonia: can we hit the target without a shotgun?. Ann Emerg Med 46 (2005) 407-408
17. Fine M.J., Auble T.E., Yealy D.M., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336 (1997) 243-250
18. Lim W.S., van der Eerden M.M., Laing R., et al. Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58 (2003) 377-382
19. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345 (2001) 1368-1377
20. Beardsley J.R., Williamson J.C., Johnson J.W., et al. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest 130 (2006) 787-793
21. Micek S.T., Dunne M., and Kollef M.H. Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production. Chest 128 (2005) 2732-2738
22. Bogdanovich T., Ednie L.M., Shapiro S., et al. Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother 49 (2005) 4210-4219
23. Kosowska K., Hoellman D.B., Lin G., et al. Antipneumococcal activity of ceftobiprole, a novel broad-spectrum cephalosporin. Antimicrob Agents Chemother 49 (2005) 1932-1942
24. Jones C.H., and Petersen P.J. Tigecycline: a review of preclinical and clinical studies of the first-in-class glycylcycline antibiotic. Drugs Today (Barc) 41 (2005) 637-659